1,2-Dichlorobenzene

1,2-Dichlorobenzene

SCHEMBL3864366

Clc1ccccc1Cl.O=S(=O)(Cl)Cl.c1ccccc1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.62
LMNA P02545 1/20 0.62
ALDH1A1 P00352 5/20 0.52
TDP1 Q9NUW8 2/20 0.52
HSD17B10 Q99714 1/20 0.52
CYP2A6 P11509 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HTR6 P50406 1/20 0.43
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
MCOLN3 Q8TDD5 1/20 0.39
IDO1 P14902 1/20 0.39
DNMT1 P26358 1/20 0.39
DNMT3L Q9UJW3 1/20 0.39
DNMT3A Q9Y6K1 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,2-Dichlorobenzene SCHEMBL792368 0.97 TSHR (0.67) TSHRLMNAALDH1A1TDP1HSD17B10
1,2-Dichlorobenzene SCHEMBL27756839 0.91 TSHR (0.59) TSHRLMNAALDH1A1TDP1HSD17B10
1,2-Dichlorobenzene SCHEMBL10452828 0.85 TSHR (0.59) TSHRLMNAALDH1A1TDP1HSD17B10
1,2-Dichlorobenzene SCHEMBL11850148 0.83 TSHR (0.91) TSHRLMNAALDH1A1CYP2A6CES2
1,2-Dichlorobenzene SCHEMBL28859926 0.81 TSHR (0.62) TSHRLMNAALDH1A1TDP1HSD17B10
1,2-Dichlorobenzene SCHEMBL29177612 0.81 TSHR (0.62) TSHRLMNAALDH1A1TDP1HSD17B10
Chlorobenzene SCHEMBL231594 0.81 TSHR (0.69) TSHRLMNAALDH1A1TDP1HSD17B10
1,2-Dichlorobenzene SCHEMBL28157020 0.79 TSHR (0.83) TSHRLMNAALDH1A1CYP2A6CES2
1,2-Dichlorobenzene SCHEMBL5190 0.79
1,2-Dichlorobenzene SCHEMBL1155123 0.79 TSHR (1.00) TSHRLMNAALDH1A1TDP1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601838-B2 2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2009-10-13 US disclosed
US-20070287723-A1 2-ALKYL/ARYL SULPHONYL-1,2,3,4-TETRAHYDRO-9H-PYRIDO (3,4-B) INDOLE-3-CARBOXYLIC ACID ESTERS/AMIDES USEFUL AS ANTITHROMBOTIC AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2007-12-13 US disclosed
WO-2006070385-A1 2-ALKYL/ARYL SULPHONYL-1,2,3,4-TETRAHYDRO-9H-PYRIDO (3,4-B) INDOLE-3-CARBOXYLIC ACID ESTERS/AMIDES USEFUL AS ANTITHROMBOTIC AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-07-06 WO disclosed
US-20060142322-A1 2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142322-A1 2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents HTR3B, TH, IDO1 TSHR 165/4885LMNA 3405/4885ALDH1A1 303/4885
US-20070287723-A1 2-ALKYL/ARYL SULPHONYL-1,2,3,4-TETRAHYDRO-9H-PYRIDO (3,4-B) INDOLE-3-CARBOXYLIC ACID ESTERS/AMIDES USEFUL AS ANTITHROMBOTIC AGENTS HTR3B, HTR3C, TH TSHR 154/4885LMNA 3353/4885ALDH1A1 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.